Role of the lipid emulsion on an injectable formulation of lipophilic KW-3902, a newly synthesized adenosine A1-receptor antagonist. | Biol Pharm Bull;25(4): 492-8, 2002 Apr. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Role of the lipid emulsion on an injectable formulation of lipophilic KW-3902, a newly synthesized adenosine A1-receptor antagonist.

Hosokawa, Toshihito; Yamauchi, Masahiro; Yamamoto, Yoshihiko; Iwata, Kenji; Mochizuki, Harumi; Kato, Yasuki.

Affiliation

Hosokawa T; Pharmaceutical Research Institute, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan. t.hosokawa@kyowa.co.jp

Biol Pharm Bull ; 25(4): 492-8, 2002 Apr.

Article in En | MEDLINE | ID: mdl-11995931

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Xanthines / Fat Emulsions, Intravenous / Purinergic P1 Receptor Antagonists Limits: Animals Language: En Journal: Biol Pharm Bull Journal subject: BIOQUIMICA / FARMACOLOGIA Year: 2002 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Xanthines / Fat Emulsions, Intravenous / Purinergic P1 Receptor Antagonists Limits: Animals Language: En Journal: Biol Pharm Bull Journal subject: BIOQUIMICA / FARMACOLOGIA Year: 2002 Document type: Article Affiliation country: Country of publication: